Balanced news tone
News Sentiment
MDLN sentiment intelligence
Medline Inc. Class A Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-5.0% over one week, +12.1% over four weeks, trend inactive, and near fair-value range.
Sumitomo Mitsui Trust Group Inc. Acquires New Shares in Medline $MDLN
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Sumitomo Mitsui Trust Group Inc. Acquires New Shares in Medline $MDLN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 08:53
- Source
- MarketBeat
Kaplan Fox & Kilsheimer LLP Alerts Medline Inc. (NASDAQ: MDLN) Investors to a Securities Investigation
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 15 Jul 2026 21:37
- Source
- NewMediaWire
Medline $MDLN Shares Bought by Mass General Brigham Inc
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 10:35
- Source
- MarketBeat
Teachers Retirement System of The State of Kentucky Has $7 Million Stock Holdings in Medline $MDLN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 10:11
- Source
- MarketBeat
Is Medline (MDLN) One of the Best Up and Coming Stocks to Invest In Right Now?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 16:35
- Source
- Market source
Lobbying Update: $80,000 of MEDLINE lobbying was just disclosed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 17:10
- Source
- Quiver Quantitative
Medline Reports Prime Vendor Agreement With Allina Health
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 15:41
- Source
- MT Newswires
Medline announces Prime Vendor agreement with Allina Health
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 15:12
- Source
- PR Newswire
Allina Health taps Medline for medical supplies across 12 hospitals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 15:12
- Source
- Stock Titan
Medline Leases Two California Distribution Centers
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 17:54
- Source
- MT Newswires
Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 14:49
- Source
- PR Newswire
After fire destroys Tracy site, Medline secures 1.6M sq. ft. in California
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Stock Titan
Medline Inc. (MDLN) Shares Up Since Jim Cramer Said It Could Be A Buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 Jul 2026 07:00
- Source
- Market source
Jim Cramer Calls Medline the “Best IPO of the Year”
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 14:19
- Source
- Insider Monkey
Medline to report second quarter 2026 results on August 5, 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jul 2026 13:00
- Source
- GlobeNewswire
Medline sets Aug. 5 call for second-quarter 2026 results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
Medline: After IPO In 2025, This Year Is A Bet On Continued Growth (NASDAQ:MDLN)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Seeking Alpha
William Blair Maintains Outperform Rating on Medline (MDLN) After Warehouse Fire
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 29 Jun 2026 07:00
- Source
- Market source
Investors of Medline Inc. (NASDAQ: MDLN) are Encouraged to Contact Kaplan Fox Regarding the Investigation of Potential Securities Law Violations
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 20 Jun 2026 07:00
- Source
- The Globe and Mail
ICUI or MDLN: Which Is the Better Value Stock Right Now?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Market source
Here is Why Medline (MDLN) is One of the Best Young Stocks with the Highest Upside Potential
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jun 2026 07:00
- Source
- Market source
Insider Purchase: Principal Accounting Officer of $MDLN Buys 5,000 Shares | MDLN Stock News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Quiver Quantitative
Medline shares rise as investors digest recent refinancing and large secondary offering | MDLN Stock News
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 09 Jun 2026 07:00
- Source
- Quiver Quantitative
Medline draws another US FDA warning in two months over quality lapses
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Reuters
Blackstone entities trim Medline (MDLN) stake with 33M-share secondary sale
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Jun 2026 07:00
- Source
- Stock Titan
UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+
- Tone
- Positive 84/100
- Event
- Earnings
- Published
- 26 May 2026 07:00
- Source
- eciks.org
Assessing Medline (MDLN) Valuation After Recent Share Price Pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- Market source
Is Medline (MDLN) Offering Opportunity After Recent Share Price Pullback And DCF Estimate?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 May 2026 07:00
- Source
- Market source
GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- StockStory
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Seeking Alpha